Published in Neuroepidemiology on June 29, 2005
Amyotrophic lateral sclerosis. Orphanet J Rare Dis (2009) 2.76
Safety and efficacy of ceftriaxone for amyotrophic lateral sclerosis: a multi-stage, randomised, double-blind, placebo-controlled trial. Lancet Neurol (2014) 1.81
Global epidemiology of amyotrophic lateral sclerosis: a systematic review of the published literature. Neuroepidemiology (2013) 1.76
Roles of the lipid peroxidation product 4-hydroxynonenal in obesity, the metabolic syndrome, and associated vascular and neurodegenerative disorders. Exp Gerontol (2009) 1.59
The role of environmental exposures in neurodegeneration and neurodegenerative diseases. Toxicol Sci (2011) 1.31
The role of environmental mercury, lead and pesticide exposure in development of amyotrophic lateral sclerosis. Neurotoxicology (2009) 1.24
Risk factors for amyotrophic lateral sclerosis. Clin Epidemiol (2015) 1.13
Age-period-cohort analysis of trends in amyotrophic lateral sclerosis in Denmark, 1970-2009. Am J Epidemiol (2013) 0.96
Infection of the central nervous system, sepsis and amyotrophic lateral sclerosis. PLoS One (2011) 0.95
Trends in death certification for multiple sclerosis, motor neuron disease, Parkinson's disease and epilepsy in English populations 1979-2006. J Neurol (2009) 0.92
Validating population-based registers for ALS: how accurate is death certification? J Neurol (2010) 0.91
Military Service and Amyotrophic Lateral Sclerosis in a Population-based Cohort. Epidemiology (2015) 0.89
Geographic distribution of amyotrophic lateral sclerosis through motor neuron disease mortality data. Eur J Epidemiol (2007) 0.87
Racial and ethnic differences among amyotrophic lateral sclerosis cases in the United States. Amyotroph Lateral Scler Frontotemporal Degener (2014) 0.86
Case-control study of occupational exposure to electric shocks and magnetic fields and mortality from amyotrophic lateral sclerosis in the US, 1991-1999. J Expo Sci Environ Epidemiol (2014) 0.82
Matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in amyotrophic lateral sclerosis (ALS). J Neural Transm (Vienna) (2014) 0.81
The management of amyotrophic lateral sclerosis. J Neurol (2009) 0.79
DJ-1 knockout augments disease severity and shortens survival in a mouse model of ALS. PLoS One (2015) 0.79
Temporal trend of amyotrophic lateral sclerosis incidence in southern Europe: a population study in the health district of Ferrara, Italy. J Neurol (2012) 0.76
Motor neuron disease mortality rates in U.S. states are associated with well water use. Amyotroph Lateral Scler Frontotemporal Degener (2016) 0.75
Adipose-derived Stem Cell Conditioned Media Extends Survival time of a mouse model of Amyotrophic Lateral Sclerosis. Sci Rep (2015) 0.75
Survival and Cause of Death among a Cohort of Confirmed Amyotrophic Lateral Sclerosis Cases. PLoS One (2015) 0.75
Reduced levels of alpha-1-antitrypsin in cerebrospinal fluid of amyotrophic lateral sclerosis patients: a novel approach for a potential treatment. J Neuroinflammation (2016) 0.75
Risk of sepsis in patients with amyotrophic lateral sclerosis: a population-based retrospective cohort study in Taiwan. BMJ Open (2017) 0.75
Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm Rep (2010) 10.59
Global illness and deaths caused by rotavirus disease in children. Emerg Infect Dis (2003) 9.44
Triple-reassortant swine influenza A (H1) in humans in the United States, 2005-2009. N Engl J Med (2009) 9.06
Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008. MMWR Recomm Rep (2008) 9.02
Rotavirus and severe childhood diarrhea. Emerg Infect Dis (2006) 7.80
Deaths: final data for 2006. Natl Vital Stat Rep (2009) 6.89
Deaths: final data for 2010. Natl Vital Stat Rep (2013) 5.95
Trends in hospitalizations for pneumonia among persons aged 65 years or older in the United States, 1988-2002. JAMA (2005) 5.84
Infections with oseltamivir-resistant influenza A(H1N1) virus in the United States. JAMA (2009) 5.84
Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Recomm Rep (2009) 5.80
Antiviral agents for the treatment and chemoprophylaxis of influenza --- recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (2011) 5.48
Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2007. MMWR Recomm Rep (2007) 5.32
Deaths: final data for 2008. Natl Vital Stat Rep (2011) 5.31
Prevention and Control of Influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (2006) 5.19
Epidemiologic and molecular trends of "Norwalk-like viruses" associated with outbreaks of gastroenteritis in the United States. J Infect Dis (2002) 4.88
Deaths: final data for 2004. Natl Vital Stat Rep (2007) 3.73
Deaths: preliminary data for 2009. Natl Vital Stat Rep (2011) 3.53
Deaths: final data for 2007. Natl Vital Stat Rep (2010) 3.45
Managing acute gastroenteritis among children: oral rehydration, maintenance, and nutritional therapy. MMWR Recomm Rep (2003) 3.32
Deaths: final data for 2009. Natl Vital Stat Rep (2011) 3.18
Deaths: preliminary data for 2008. Natl Vital Stat Rep (2010) 3.12
The relationship between in-home water service and the risk of respiratory tract, skin, and gastrointestinal tract infections among rural Alaska natives. Am J Public Health (2008) 3.09
Rotavirus vaccines: current prospects and future challenges. Lancet (2006) 2.97
A novel human disease with abnormal prion protein sensitive to protease. Ann Neurol (2008) 2.95
Annual summary of vital statistics: 2005. Pediatrics (2007) 2.92
Outbreaks of acute gastroenteritis on cruise ships and on land: identification of a predominant circulating strain of norovirus--United States, 2002. J Infect Dis (2004) 2.88
Serotype diversity and reassortment between human and animal rotavirus strains: implications for rotavirus vaccine programs. J Infect Dis (2005) 2.82
Estimates of US influenza-associated deaths made using four different methods. Influenza Other Respir Viruses (2009) 2.82
Pandemic influenza and pregnant women. Emerg Infect Dis (2008) 2.80
Cost-effectiveness and potential impact of rotavirus vaccination in the United States. Pediatrics (2007) 2.75
Deaths: final data for 2000. Natl Vital Stat Rep (2002) 2.65
Norovirus and foodborne disease, United States, 1991-2000. Emerg Infect Dis (2005) 2.57
Myocardial injury and bacterial pneumonia contribute to the pathogenesis of fatal influenza B virus infection. J Infect Dis (2012) 2.48
Chronic wasting disease of elk: transmissibility to humans examined by transgenic mouse models. J Neurosci (2005) 2.46
The future of rotavirus vaccines: a major setback leads to new opportunities. Lancet (2004) 2.43
Outbreak of variant influenza A(H3N2) virus in the United States. Clin Infect Dis (2013) 2.38
Kawasaki syndrome hospitalizations in the United States, 1997 and 2000. Pediatrics (2003) 2.36
Viral respiratory infections in hospitalized and community control children in Alaska. J Med Virol (2010) 2.29
Rickettsia parkeri rickettsiosis and its clinical distinction from Rocky Mountain spotted fever. Clin Infect Dis (2008) 2.27
Deaths: final data for 2001. Natl Vital Stat Rep (2003) 2.26
Lower respiratory tract infections among american Indian and Alaska Native children and the general population of U.S. Children. Pediatr Infect Dis J (2005) 2.07
Kawasaki syndrome and factors associated with coronary artery abnormalities in California. Pediatr Infect Dis J (2012) 2.03
Management of neurosurgical instruments and patients exposed to Creutzfeldt-Jakob disease. Infect Control Hosp Epidemiol (2013) 2.02
Iatrogenic Creutzfeldt-Jakob disease, final assessment. Emerg Infect Dis (2012) 2.01
Ebola virus disease in health care workers--Sierra Leone, 2014. MMWR Morb Mortal Wkly Rep (2014) 1.99
Strategy to enhance influenza surveillance worldwide. Emerg Infect Dis (2009) 1.99
Rocky mountain spotted fever in the United States, 2000-2007: interpreting contemporary increases in incidence. Am J Trop Med Hyg (2010) 1.99
Necrotising enterocolitis hospitalisations among neonates in the United States. Paediatr Perinat Epidemiol (2006) 1.97
Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP) -- United States, 2014-15 influenza season. MMWR Morb Mortal Wkly Rep (2014) 1.97
Annual summary of vital statistics--2003. Pediatrics (2005) 1.95
Burden of encephalitis-associated hospitalizations in the United States, 1988-1997. Clin Infect Dis (2002) 1.92
Infectious disease hospitalizations among infants in the United States. Pediatrics (2008) 1.90
Chronic wasting disease and potential transmission to humans. Emerg Infect Dis (2004) 1.87
Long-term mortality in the United States cohort of pituitary-derived growth hormone recipients. J Pediatr (2004) 1.84
Deaths: Final Data for 2013. Natl Vital Stat Rep (2016) 1.83
Respiratory syncytial virus hospitalizations among American Indian and Alaska Native infants and the general United States infant population. Pediatrics (2004) 1.83
The epidemiology of rotavirus diarrhea in Latin America. Anticipating rotavirus vaccines. Rev Panam Salud Publica (2004) 1.80
Hospitalizations for Kawasaki syndrome among children in the United States, 1997-2007. Pediatr Infect Dis J (2010) 1.78
Mortality in the United States, 2013. NCHS Data Brief (2014) 1.75
Estimating influenza-associated deaths in the United States. Am J Public Health (2009) 1.73
Economic costs of rotavirus gastroenteritis and cost-effectiveness of vaccination in developing countries. J Infect Dis (2009) 1.72
Clinical manifestations of human monkeypox influenced by route of infection. J Infect Dis (2006) 1.71
Substantial variability in community respiratory syncytial virus season timing. Pediatr Infect Dis J (2003) 1.71
Epidemiology of human ehrlichiosis and anaplasmosis in the United States, 2001-2002. Am J Trop Med Hyg (2005) 1.69
Pathology and pathogenesis of fatal Bordetella pertussis infection in infants. Clin Infect Dis (2008) 1.68
Variably protease-sensitive prionopathy: a new sporadic disease of the prion protein. Ann Neurol (2010) 1.66
Diarrhea- and rotavirus-associated hospitalizations among children less than 5 years of age: United States, 1997 and 2000. Pediatrics (2006) 1.64
Influenza Illness and Hospitalizations Averted by Influenza Vaccination in the United States, 2005-2011. PLoS One (2013) 1.64
Prevention and Control of Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2015-16 Influenza Season. MMWR Morb Mortal Wkly Rep (2015) 1.64
Kawasaki syndrome hospitalizations among children in the United States, 1988-1997. Pediatrics (2003) 1.62
The global burden of diarrhoeal disease in children. Bull World Health Organ (2003) 1.61
A waterborne outbreak of Norwalk-like virus among snowmobilers-Wyoming, 2001. J Infect Dis (2002) 1.54
Cluster of SARS among medical students exposed to single patient, Hong Kong. Emerg Infect Dis (2004) 1.49
Health care costs of diarrheal disease and estimates of the cost-effectiveness of rotavirus vaccination in Vietnam. J Infect Dis (2005) 1.47
Assessing the risk of laboratory-acquired meningococcal disease. J Clin Microbiol (2005) 1.47
Burden of encephalitis-associated hospitalizations in the United States, 1998-2010. Neurology (2014) 1.47
Kawasaki syndrome and risk factors for coronary artery abnormalities: United States, 1994-2003. Pediatr Infect Dis J (2006) 1.46
Infectious disease hospitalizations in the United States. Clin Infect Dis (2009) 1.43
Evaluation of potential infectivity of Alzheimer and Parkinson disease proteins in recipients of cadaver-derived human growth hormone. JAMA Neurol (2013) 1.42
Iatrogenic Creutzfeldt-Jakob disease in Australia: time to amend infection control measures for pituitary hormone recipients? Med J Aust (2010) 1.39
Trends in preterm-related infant mortality by race and ethnicity, United States, 1999-2004. Int J Health Serv (2007) 1.37
Hospitalizations associated with rotavirus gastroenteritis in the United States, 1993-2002. Pediatr Infect Dis J (2006) 1.35
Rotavirus vaccines: targeting the developing world. J Infect Dis (2005) 1.35
The public health impact of prion diseases. Annu Rev Public Health (2005) 1.33
Prevention and Control of Seasonal Influenza with Vaccines. MMWR Recomm Rep (2016) 1.32
Human infections with influenza A(H3N2) variant virus in the United States, 2011-2012. Clin Infect Dis (2013) 1.32
Seasonal trends of human parainfluenza viral infections: United States, 1990-2004. Clin Infect Dis (2006) 1.30
Kawasaki syndrome in Denmark. Pediatr Infect Dis J (2007) 1.24
Kawasaki syndrome in Hawaii. Pediatr Infect Dis J (2005) 1.24
Sentinel hospital surveillance for rotavirus diarrhea in the People's Republic of China, August 2001-July 2003. J Infect Dis (2005) 1.22
Evaluation of smallpox vaccines using variola neutralization. J Gen Virol (2009) 1.21
Monitoring the occurrence of emerging forms of Creutzfeldt-Jakob disease in the United States. Neurology (2003) 1.19
Infection control practices and zoonotic disease risks among veterinarians in the United States. J Am Vet Med Assoc (2008) 1.18